Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
11.49
16.96
147.61%
Share Warrants & Outstandings
Total Reserve
107.51
11.06
96.45
872.06%
Shareholder's Funds
138.48
22.54
115.94
514.37%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
0.00
1.99
0.00%
Secured Loans
1.99
0.00
1.99
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.92
0.41
0.51
124.39%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.03
-0.03
-100.00%
Total Non-Current Liabilities
2.91
0.43
2.48
576.74%
Current Liabilities
Trade Payables
102.54
1.35
101.19
7,495.56%
Other Current Liabilities
11.07
0.39
10.68
2,738.46%
Short Term Borrowings
32.87
0.00
32.87
0.00%
Short Term Provisions
2.73
0.00
2.73
0.00%
Total Current Liabilities
149.21
1.74
147.47
8,475.29%
Total Liabilities
290.59
24.72
265.87
1,075.53%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
1.05
38.05
3,623.81%
Less: Accumulated Depreciation
22.88
0.62
22.26
3,590.32%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
0.43
15.79
3,672.09%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
10.03
-7.91
-78.86%
Long Term Loans & Advances
6.64
0.00
6.64
0.00%
Other Non Current Assets
0.01
3.56
-3.55
-99.72%
Total Non-Current Assets
24.98
14.02
10.96
78.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
0.78
44.70
5,730.77%
Sundry Debtors
133.46
0.85
132.61
15,601.18%
Cash and Bank
1.47
1.28
0.19
14.84%
Other Current Assets
0.78
0.19
0.59
310.53%
Short Term Loans and Advances
84.41
7.59
76.82
1,012.12%
Total Current Assets
265.61
10.69
254.92
2,384.66%
Net Current Assets (Including Current Investments)
116.40
8.96
107.44
1,199.11%
Total Current Assets Excluding Current Investments
265.61
10.69
254.92
2,384.66%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
24.72
265.87
1,075.53%
Contingent Liabilities
0.00
0.63
-0.63
-100.00%
Total Debt
34.86
0.00
34.86
0.00%
Book Value per share (adjusted)
46.90
19.63
27.27
138.92%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
